EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
Top Cited Papers
- 1 June 2016
- journal article
- practice guideline
- Published by Elsevier BV in Journal of Hepatology
- Vol. 64 (6), 1388-1402
- https://doi.org/10.1016/j.jhep.2015.11.004
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trialJournal of Hepatology, 2011
- Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and AdolescentsJAMA, 2011
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meaningsJournal of Hepatology, 2010
- A position statement on NAFLD/NASH based on the EASL 2009 special conferenceJournal of Hepatology, 2010
- High-dose ursodeoxycholic acid therapy for nonalcoholic steatohepatitis: a double-blind, randomized, placebo-controlled trialJournal of Hepatology, 2010
- Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitisJournal of Hepatology, 2009
- Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): A histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research networkJournal of Hepatology, 2008
- Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markersJournal of Hepatology, 2007
- Mortality in Randomized Trials of Antioxidant Supplements for Primary and Secondary PreventionJAMA, 2007
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseJournal of Hepatology, 2005